Presented on August 5th, 2022.
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about PepGen.
- Alayna Tress, MPH, Associate Director of Patient Advocacy
- Michelle Mellion, MD, Senior Vice President & Head of Clinical Development
- Jaya Goyal, PhD, Executive Vice President of Research & Preclinical Development
- Holly Hand, Clinical Operations Consultant
- Jane Larkindale, DPhil, Vice President of Clinical Science